You can follow the trail.

Read in full. Recommends oral appliances for adults with primary snoring who want treatment, after a sleep physician has assessed them. Prefers custom, adjustable devices for people with sleep apnoea (based on low-quality evidence).

German national guideline on snoring in adults. Read with AI-assisted translation. Its current validity was not confirmed; it may be awaiting an update.

German independent consumer test, October 2021. None of 23 products reliably stopped snoring; it advises seeing a dentist or ENT doctor first. Individual product ratings are behind a paywall and were not read.

Read. 50 couples randomised, 42 finished; adults who snore without sleep apnoea. Four weeks. Outcome was the bed partner’s rating, not a recording. Analysed only those who finished.

Read. Nine studies, 235 people. Mostly weak study designs; results for snoring were mixed.

Trial record read. 39 people with primary snoring or mild-to-moderate sleep apnoea, three months. Exercises reduced snoring measured in a sleep lab. The comparison group used nasal strips plus breathing exercises and showed no significant change.

News report read. Two manufacturer-funded trials (140 and 130 adults with chronic night-time nasal congestion, 14 days). Strips did not improve sleep problems more than placebo strips. They measured sleep in congested people, not snoring.

Read. 14 studies, 147 people with sleep apnoea. No significant change in breathing events, oxygen levels or snoring index. Small, varied studies.

English abstract read. Twelve selected participants; snoring frequency and loudness gave different results.

English abstract read. Eighteen participants; opening the nose did not reduce snoring duration or intensity.

Abstract read. 41 people, open design, snoring time measured with a phone. Snoring time fell with both devices; the internal dilator (Nas-air) did better. No placebo group.

Abstract read. Participants had sleep-disordered breathing, not simple snoring. The first author developed the device later sold as Good Morning Snore Solution. Sample size is not shown in the abstract.

Abstract read. 30 people with snoring and sleep apnoea, compared with themselves before and after three months. The abstract does not name the device, so we can’t confirm it tested Somnofit-S.

Full text read. No significant difference in the main breathing outcome on the first night after surgery; snoring was not measured. 12% removed the device within two hours because of jaw discomfort.

Press release read; the full paper (Western University, Canada) could not be opened in our check. 10 studies, 213 people. Two found a slight improvement in breathing events in some people with mild sleep apnoea; the rest found no benefit. Four raised a suffocation risk for people with a blocked nose. Snoring was not specifically addressed.

Dental-hygiene journal article read. We couldn’t open the original papers it summarises: a 2022 study of 20 mouth-breathers with mild sleep apnoea (no control group, one week) and a 2015 pilot of 30 people using a porous mouth patch.

Cleared in 2017 as an over-the-counter aid to reduce snoring in adults; not for sleep apnoea. The submission lists usability and biocompatibility testing, not an effectiveness trial. Whether it covers SnoreRx Plus was not confirmed.

The record names SOMNOFIT, not Somnofit-S. We have not confirmed that it covers the model sold today.

Manufacturer information on fit, exclusions and side effects. Not independent evidence of effectiveness.

Seller information. Describes the device as FDA-cleared for snoring only. Marketing statements are not treated as verified results.

Swiss manufacturer page. Lists use for snoring and mild-to-moderate sleep apnoea, exclusions, and a typical life of 8–15 months with replacement by 18 months. Its 55% figure refers to oral appliances in general, not this model.

French version of the manufacturer page, read with AI-assisted translation. Same exclusions and general-appliance figure as the English page.

Manufacturer information on use limits and skin care. Not independent evidence of effectiveness.

Hong Kong distributor page in Traditional Chinese. Includes a statement that the product is not intended to diagnose, treat or prevent disease.

Japanese manufacturer FAQ, read with AI-assisted translation.

Manufacturer FAQ, used for instructions only. Versions sold elsewhere can differ.

Manufacturer FAQ. Replace each device after ten uses; not for treating sleep apnoea; not for children under 12. Its “up to 38% more airflow” figure has no source attached.

Manufacturer information. Not independent evidence of effectiveness.

90-day money-back guarantee; trial kits where you only paid shipping can’t be returned. US terms; other markets not checked.

Company blog, not a published study. Three weeks without, three weeks with; number of people not stated; mostly self-reported outcomes; snoring was not measured.

Press release for an online survey of 300 people who had used nasal strips, run in February 2026. Issued by a company, Moon Moon Co., Ltd. Self-reported; not a clinical study.

Registry fields read in an earlier check. Marked completed, with results listed as unpublished. A listing is not a result.

Public health education, read in an earlier check. We could not reopen it in our latest check to confirm the author. Not a study.